SlideShare a Scribd company logo
1 of 26
Download to read offline
Safety and health at work is everyone’s concern. It’s good for you. It’s good for business.
Biological agents and prevention of work-related
diseases: a review
© EU-OSHA, Matej Kastelic
2
https://osha.europa.eu
Background of the project
 EU OSH Strategic Framework 2014-2020
• One of the 3 major challenges: to improve the prevention of work-related diseases
 Background
• 230,000 workers died worldwide in 2014 due to communicable diseases caused by
biological agents – around 7,000 in Europe
(GLOBAL ESTIMATES 2017)
• About 15% of cancers attributed to carcinogenic infections, (Helicobacter pylori,
Human papillomavirus (HPV), Hepatitis B, C, Epstein-Barr, etc.) (WHO)
• FR (2010): 4,7 million workers (22%) exposed to biological agents
−healthcare/social work (74.9%), agriculture (38.8 %), Horeca (44.7 %), personal
services (58.8 %), green jobs (46.4%) (SUMER 2010)
• Waste management and healthcare are growing sectors
3
https://osha.europa.eu
Part of OSH overview on work-related diseases
 2015-2019
− Desk research, expert interviews and focus groups
− Description of policies or monitoring systems and data analysis
− Workshops with experts and EU-OSHA stakeholders
 Outputs:
− Seminar online summaries, literature reviews, reports, articles and
recommendations, ppts for policy makers and for experts
− Translations – portfolio approach: articles, report summaries,
− National workshops under FAST 2019
 Building on previous EU-OSHA work
− Dangerous substances incl. biological agents, etc.
©EU-OSHA, Roberta Pizzigoni
4
https://osha.europa.eu
Objectives of the review
 Raise awareness on exposure to biological agents in exposed
professions, especially those with unintentional use of biological
agents;
 Increase information on health problems related to exposure
to biological agents;
 Support efforts to prioritise and structure the prevention of
work-related health problems linked to biological agents.
©Shutterstock/DariaCherry
 Overview on the current knowledge on relevant exposures and on recognised diseases;
 Particular focus on emerging issues and new professions, e.g. green jobs;
 Link to biological agents directive – unintentional exposures;
 Collect information from recording and compensation systems;
 Identify gaps in data/knowledge.
5
https://osha.europa.eu
Complementary to previous and ongoing work
EU-OSHA campaigns
European Week 2003 and HWC 2018-19
Expert Forecast: Main emerging biological risks
 Global epidemics (avian flu, HIV, etc.)
• Workers at the frontline of contamination
 Drug-resistant micro-organisms (MRSA, tuberculosis, etc.)
 Poor Indoor Air Quality: Indoor mould
• Poor maintenance of air-conditioning, construction & insulation technics
 Waste treatment: micro-organisms, mould, endotoxins, etc.
 Poor risk assessment: little information on dose-effect relationship;
measurement is challenging; low awareness level
Selected reviews:
 Legionella and Legionnaires’ disease: a policy overview
 Biological agents and pandemics: review of the literature and national
policies
6
https://osha.europa.eu
Beneficiaries & intermediaries
 Beneficiaries
• Policy makers at national and EU level, including social partners;
• Legislators;
• Researchers;
• Actors in occupational diseases recognition and statistical data collection
(e.g. national social security organisations);
• Actors at enterprise level (e.g. health and safety manager, health and
safety representative, trades union representative) and intermediaries
involved in setting up company policies;
• Sectoral organisations;
• Policy makers in other, related areas, for example at the sectoral level, or
regarding employment, public health and environmental policies.
 Intermediaries
• Intermediaries involved in setting up company policies;
• Sectoral organisations
• Policy makers at national and EU level, incl. social partners
• Researchers
©INSHT
7
https://osha.europa.eu
Project overview: structure
 Task-specific objectives:
• Task 1: provide overview of types of biological
factors and health problems relevant to
workplaces (emphasis on unintentional
exposures)
• Task 2: provide information on examples of
policies regarding work-related diseases due
to biological agents, their success factors and
obstacles and their transferability
• Task 3: learn from the experience of
intermediaries to identify specific upcoming
risks and lack of measures regarding work-
related diseases due to biological agents
• Task 4: Stakeholder workshop to present and
discuss findings
• Task 5: Final report summarizing results
8
https://osha.europa.eu
Results
 Workers exposed in many professions, but little
information on prevalence or incidence of exposure or diseases
 High risk sectors: healthcare, agriculture (arable farming and
livestock farming), waste and wastewater treatment, occupations
that involve travelling and contact with travellers.
 Other professions: wood working, metal work, restauration (of
artworks), archives, etc..
© EU-OSHA, Verislav Stanchev
 Overall lack of awareness of the risks from biological agents in all sectors, except healthcare
and laboratories
 Exposure to mixtures:
• organic dust in agriculture and other professions, causing infections and allergies
• surgical smoke
 Allergenic agents, sectors and occupations at clear risk:
• agricultural and fisheries sector, food industry, wood-working and metal industry and the waste
treatment sector
• well known allergenic occupational diseases are asthma in farmers and farmer's lung
(hypersensitivity pneumonitis)
9
https://osha.europa.eu
Emerging biological risks
 Climate change --> newly occurring microorganisms that
have spread to other regions (e.g. via ticks and mosquitoes)
 Environmental legislation leading to changing patterns in waste
management
 Waste treatment and composting - specific allergens
 Changing travelling patterns and volunteer schemes in third
world countries (chikungunya, Crimean-Congo fever)
©EU-OSHA, Audrius Bagdonas
 Migration flow to Europe – transfer of biological agents from the Middle East and Africa
 Multi-resistant bacteria and epidemics (e.g. of zoonoses), risk to health professions and agriculture
 Expected increase in green jobs - increased sensitisation to biomass-related allergens
 Potential re-emerging diseases, e.g. Q-fever, tuberculosis and influenza
No system in place to respond quickly to emerging risks
10
https://osha.europa.eu
Vulnerable groups
 For most occupations, no specific information
 Critical doses and circumstances of exposure may be different for these groups
 Trainees and new professionals, young workers  lack of experience & knowledge
 Pregnant women
 People with pre-existing diseases, like lung diseases, allergies and asthma, chronic
diseases
 People treated with immunosuppressants, especially fungal diseases
 Cleaning and maintenance workers, working at different workplaces and for different
employers
 Temporary and undocumented workers
 Foreign workers
 Healthcare:
• Workers in home care (not always well informed)
• Health workers who travel for work
Courtesy of AUVA
11
https://osha.europa.eu
Monitoring of diseases (1)
 A selection of monitoring systems analysed and described (DE,
DK, FI, FR, NL, UK)
 Wide range of types of monitoring systems for diseases
 Diseases due to biological agents reported in generic registration
systems  no specific focus on biological agents
• Exceptions in healthcare and systems for compulsory reporting (e.g.
for hepatitis or tuberculosis)
 Proportion of diseases due to biological agents relatively low,
except allergic diseases
 Unequal coverage of zoonoses
 Coverage of sectors and occupations unequal
• e.g. agriculture, self-employed
‼ Underreporting of diseases (including those related to biological
agents)
©EU-OSHA, Dominic Wigley
12
https://osha.europa.eu
Monitoring of diseases (2)
 Systems used for monitoring diseases / exposures vary widely:
• Differences in what is monitored, how frequently and level of detail
• Under-reporting
• Little information on exposure to biological agents at the workplace
 Unclear how data from monitoring systems is linked to
prevention at the workplace
 Data from national registration systems on occupational diseases
and causes can be a valuable source of information
• Data often not publicly available
• Available in NL and UK
• Difficult for companies or branch organisations to access information
relevant for their sector
 Risk of biological agents often not a high priority on the national
political agenda due to lack of clear evidence, occupational
exposure limit (OEL) values and evaluation methods
© CRISTINA VATIELLI
13
https://osha.europa.eu
Monitoring of exposures to biological agents
 Information on exposure to biological agents limited
Monitoring systems do not exist in all countries
• Of evaluated countries, only in Germany, France and Finland occupational exposures monitored
and registered on regular basis.
 Exposures not measured frequently
 Possible to derive occupational exposure limits (OELs) for biological agents that have toxic
or allergenic effects as for chemicals (e.g. endotoxins) BUT
• Lack of data on exposure and effects (exposure-effect relationships)
• Lack of knowledge on exposure and pathogenicity
© Fotolyse - Fotolia
 Innovative measurement methods for identification and
exposure easurement
 FINJEM, MEGA database, COLCHIC database
 French TOE as a basis for categories of exposure
14
https://osha.europa.eu
Challenges for measurement of biological agents
 Exposure depends on growth conditions, availability of water and other substrates
 Dependent on temperature/season of the year.
! A measurement can only be regarded as a snapshot of the concentration in the air.
 Measurement methods record concentrations in air, but not from contaminated surfaces or
instruments and through skin
 Cultivation and colony counting does not capture substances generated by the organisms,
or toxic/allergenic compounds. Some cannot be measured through cultivation
©EU OSHA/Jim Holmes
 Alternative methods
 (electron)microscope counting
 DNA sequencing or staining
 Focus on more general markers for exposure (like endotoxins,
glucans, peptidoglycans)
 Stimulate development of standardised measurement methods
and OELs for these markers
15
https://osha.europa.eu
Monitoring systems - recommendations
 To achieve comparability
• Make information available to all stakeholders
• Use a standard set of key parameters
• Agree on the level of detail.
• Consider providing information in English
 Output from the systems in each
country should be published according to
• Causative agents (exposures)
• Industries/sectors
• Jobs/occupations
• Age
• Gender
 All sectors and occupations and all groups of workers to be covered by disease monitoring,
recording and recognition
 Good examples: Classification systems in France (TOE) or in Germany (TRBAs, GESTIS)
©EU-OSHA, Sandra Milosevic
16
https://osha.europa.eu
Monitoring systems – recommendations (2)
 Regular revision and update of the lists of occupational diseases
 Emphasis on respiratory diseases and skin diseases and on
exposures to service workers
 Better use of the information in existing databases
 ‘ODIT’ instrument (Spreeuwers et al. 2009) - tool to assess quality
of registration systems for occupational disease and ability to provide
information for prevention
 Defined indicators for high and low quality
 Detection of new and/or emerging risks requires a different
strategy / instruments than current risks
• Training and commitment from (occupational) physicians
• FR, BE/NL: examples of detection systems (RNV3P, Signaal) ©PIXELTASTER, Arpad Pinter
17
https://osha.europa.eu
Better prevention needed
 Respecting the hierarchy of prevention measures
• Most measures identified in the review related to PPE and other
individual measures
• Awareness-raising needed about the existing legal framework
• Applying collective rather than personal measures
 Lack of access to appropriate PPE or lack of appropriate storage
areas for PPE
 Plans to deal with accidental exposure
 Measures for safe waste collection and handling and transport of
biological agents
 OSH services needed for workers in exposed sectors
 Right to appropriate health surveillance
• needs to lead to prevention measures
• right for other workers when a health problem is identified
• prescreening for allergy vs. prevention measures ©Stoyko Sabotanov
©Dries Vanderschaeghe
18
https://osha.europa.eu
Better prevention (2)
 Hygiene measures
• separation of break and changing rooms
• appropriate washing and toilet facilities
• separation of work and other clothing
 Differentiation between ‘clean’ and ‘dirty’ areas (black-white areas)
• especially in waste management and farming
• avoiding contamination
 Vaccination
• right for workers to be informed about advantages/disadvantages
• information in annexes to biological agents Directive (label)
• reasons for low vaccination rates?
 Protection from accidental exposure
• needlestick injuries, cuts, bites
• diseases transmitted by vectors (e.g. Ticks)
©EU OSHA/Jim Holmes
©Manuel Alejandro Ortega Gálvez
©EU OSHA/Jim Holmes
19
https://osha.europa.eu
Importance of allergens
 Multifactorial - exact cause of the allergy cannot easily be
identified
 Causes: organic dust, moulds in buildings, flour dust,
industrial enzymes, specific bacteria occurring for
example in waste management, wood processing and
metalwork
 Sectors at risk: waste and wastewater treatment,
construction, fisheries, food industry, textile industry,
wood-working, metal industry
! Allergies most recognised diseases, e.g. farmers lung
 Prevention:
• Dust- and aerosol-avoiding measures
• Ventilation
• Closed systems
• Hygiene measures
• PPE
• Black-white areas
©Audrius Bagdonas
©INSHT
20
https://osha.europa.eu
Conclusions
 Classification of biological agents according to level of risk requires a
risk assessment for every biological agent at a workplace
• often not feasible due to the large variation of biological agents at
workplaces
• for many biological agents no data available
 Huge variation in conditions of workplaces means a uniform
preventive approach is difficult to realise.
 Policies mentioned by experts for all sectors successful
• Facilitated by:
− good national visibility and approachability of experts,
− availability of research results and reports,
− lobbying groups, media attention and public awareness.
• Obstacles:
− a lack of effective methods to collect quantified data,
− lack of a clear reporting system for emerging diseases and risky
situations from local to national level
− lack of collaboration between ministries, expert organisations and
other relevant stakeholders.
©EU-OSHA, Raymond Widawski
21
https://osha.europa.eu
Good practice examples
 OSH services for farming sector – Finland
• Consultation and health checks for farmers
 Technical rules for biological agents, GESTIS database –
Germany
• Guidance for different sectors and biological agents
 Cooperation of committees for hazardous substances
and for biological agents - Germany
• Guidance for protection of workers from sensitisers
 Prevention in animal laboratories – Netherlands
• Mixture of organisational, technical and personal measures
to protect workers from allergies
• Apply to workers, clients and providers
 Sentinel and alert systems
• RNV3P – France
• THOR – UK
• SIGNAAL – Belgium and Netherlands
©Timurs Subhankulovs
22
https://osha.europa.eu
Synergies with public health needed!
 Compulsory reporting in public health for some diseases and
exposures:
• Pandemics such as avian influenza
• Tuberculosis
• Brucellosis, etc…
 Monitor spread and outbreaks of diseases
 Sentinel approach as in public health notification systems
could be followed
 Expert networks in public health and occupational hygiene, e.g.
regarding antibiotics and multiple resistance
 General practitioners can act as mediators for the prevention
message and are important carriers of information
 Clear intervention plan when a new risk is identified – from first
signs to alert for prevention
©EU-OSHA, Zijl Reinier
23
https://osha.europa.eu
Recommendations – awareness-raising and communication
 Better link between research community, authorities and the OSH
experts at workplaces
 Information exchange needed between countries
• filling the gaps by additional research
• existing data, knowledge, experiences and best practices in different
sectors
• more systematic assessments of specific exposures or specific
occupations
• communication to benefit policy makers and workers/employers ©David Tijero Osorio
 Raising more awareness:
• among occupational physicians - observing an increase in incidence of known diseases in novel
occupational settings
• among general practitioners - possible link between observed health effects and (previous) work
environment of a patient
• among new / young workers in relevant sectors and
occupations, through e.g. vocational education
• among employers on their legal obligations
24
https://osha.europa.eu
Recommendations – European level
 Consider wider definition of biological agents:
• In addition to living (micro)organisms, substances or structures
from living or dead organisms (such as exotoxins), allergens and
mixtures of biological agents (bioaerosols or organic dust)
• Broader definition of biological agents already applied in various
Member States
• Synergy of requirements for chemical agents and biological agents
 A wider range of occupations considered to be ‘at risk’ should
be taken into account in the Directive or guidance
• Take into account unintentional exposure situations
• Take into account “risky” jobs (e.g. maintenance workers, cleaners)
 Include reference to vulnerable groups
 Emerging risks:
• European (or even global) (warning) system would make it possible
to respond to emerging risks more quickly and in a more structured
way
• Alert function in existing or new systems
©David Tijero Osorio
25
https://osha.europa.eu
Thank you for your attention
Visit our webpages
https://osha.europa.eu/en/themes/work-related-diseases/biological-agents
26
https://osha.europa.eu
Copyright
©European Agency for Safety and Health at Work, 2019
Reproduction is authorised provided the source is acknowledged.
For reproduction or use of any photo under any other copyright than EU-OSHA,
permission must be sought directly from the copyright holder.

More Related Content

What's hot

Introduction to occupational health
Introduction to occupational healthIntroduction to occupational health
Introduction to occupational healthInteger
 
Brief Review On occupational hazards
Brief Review On occupational hazardsBrief Review On occupational hazards
Brief Review On occupational hazardsBabitha Devu
 
Occupational health surveillence
Occupational health surveillenceOccupational health surveillence
Occupational health surveillenceDalia El-Shafei
 
Occupational health and safety
Occupational health and safetyOccupational health and safety
Occupational health and safetyRuppaMercy
 
Biological hazards overview
Biological hazards overviewBiological hazards overview
Biological hazards overviewmcivers1979
 
Introduction to occupational health
Introduction to occupational healthIntroduction to occupational health
Introduction to occupational healthDr Azfar Malik
 
Occupational health
Occupational healthOccupational health
Occupational healthSiva Mbbs
 
Industrial hygiene
Industrial hygieneIndustrial hygiene
Industrial hygieneladdha1962
 
occupational hazard
 occupational hazard occupational hazard
occupational hazardAsmin Fayiz
 
Introduction to occupational diseases
Introduction to occupational diseasesIntroduction to occupational diseases
Introduction to occupational diseasesDrZahid Khan
 
Topic no.1 occupationa health
Topic no.1  occupationa healthTopic no.1  occupationa health
Topic no.1 occupationa healthEiyla Hamdan
 
Occupational health hazards
Occupational health hazardsOccupational health hazards
Occupational health hazardsjigisha pancholi
 
Occupational hazards: Meaning, Types and Prevention
Occupational hazards: Meaning, Types and PreventionOccupational hazards: Meaning, Types and Prevention
Occupational hazards: Meaning, Types and PreventionNEETHU S JAYAN
 
Occupational diseases (Part 3) -Industrial hazards and Plumbism
Occupational diseases (Part 3) -Industrial hazards and PlumbismOccupational diseases (Part 3) -Industrial hazards and Plumbism
Occupational diseases (Part 3) -Industrial hazards and PlumbismMohsin Ansari
 
Principles of Occupational Health
Principles of Occupational HealthPrinciples of Occupational Health
Principles of Occupational HealthAzmi Mohd Tamil
 
Applied ergonomics-for-nurses-and-health-care-workers-slides
Applied ergonomics-for-nurses-and-health-care-workers-slidesApplied ergonomics-for-nurses-and-health-care-workers-slides
Applied ergonomics-for-nurses-and-health-care-workers-slidesSANJAY SIR
 

What's hot (20)

Introduction to occupational health
Introduction to occupational healthIntroduction to occupational health
Introduction to occupational health
 
Brief Review On occupational hazards
Brief Review On occupational hazardsBrief Review On occupational hazards
Brief Review On occupational hazards
 
Occupational health surveillence
Occupational health surveillenceOccupational health surveillence
Occupational health surveillence
 
Occupational diseases
Occupational diseasesOccupational diseases
Occupational diseases
 
Occupational health and safety
Occupational health and safetyOccupational health and safety
Occupational health and safety
 
Occupational hazards
Occupational hazardsOccupational hazards
Occupational hazards
 
Biological hazards overview
Biological hazards overviewBiological hazards overview
Biological hazards overview
 
Introduction to occupational health
Introduction to occupational healthIntroduction to occupational health
Introduction to occupational health
 
Occupational health
Occupational healthOccupational health
Occupational health
 
Industrial hygiene
Industrial hygieneIndustrial hygiene
Industrial hygiene
 
occupational hazard
 occupational hazard occupational hazard
occupational hazard
 
Introduction to occupational diseases
Introduction to occupational diseasesIntroduction to occupational diseases
Introduction to occupational diseases
 
Topic no.1 occupationa health
Topic no.1  occupationa healthTopic no.1  occupationa health
Topic no.1 occupationa health
 
Occupational health hazards
Occupational health hazardsOccupational health hazards
Occupational health hazards
 
Prevention of injuries occupational health
Prevention of injuries occupational health Prevention of injuries occupational health
Prevention of injuries occupational health
 
Occupational hazards: Meaning, Types and Prevention
Occupational hazards: Meaning, Types and PreventionOccupational hazards: Meaning, Types and Prevention
Occupational hazards: Meaning, Types and Prevention
 
Occupational diseases (Part 3) -Industrial hazards and Plumbism
Occupational diseases (Part 3) -Industrial hazards and PlumbismOccupational diseases (Part 3) -Industrial hazards and Plumbism
Occupational diseases (Part 3) -Industrial hazards and Plumbism
 
Principles of Occupational Health
Principles of Occupational HealthPrinciples of Occupational Health
Principles of Occupational Health
 
Physical hazards
Physical hazardsPhysical hazards
Physical hazards
 
Applied ergonomics-for-nurses-and-health-care-workers-slides
Applied ergonomics-for-nurses-and-health-care-workers-slidesApplied ergonomics-for-nurses-and-health-care-workers-slides
Applied ergonomics-for-nurses-and-health-care-workers-slides
 

Similar to Biological agents and prevention of work-related diseases: a review for experts

A healthy environment in Europe for healthier people
A healthy environment in Europe for healthier peopleA healthy environment in Europe for healthier people
A healthy environment in Europe for healthier peopleCéline Charveriat
 
Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)
Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)
Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)THL
 
The relevance of the farming community regarding zoonoses
The relevance of the farming community regarding zoonosesThe relevance of the farming community regarding zoonoses
The relevance of the farming community regarding zoonosesHarm Kiezebrink
 
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum
 
Catherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCatherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCittadinanzattiva onlus
 
European Platform for Chronic and Respiratory Diseases
European Platform for Chronic and Respiratory DiseasesEuropean Platform for Chronic and Respiratory Diseases
European Platform for Chronic and Respiratory DiseasesGlobal Risk Forum GRFDavos
 
Timo Minssen - Helex Presentation on Law & Antibiotics
Timo Minssen - Helex Presentation on Law & AntibioticsTimo Minssen - Helex Presentation on Law & Antibiotics
Timo Minssen - Helex Presentation on Law & AntibioticsKristine Sorgenfri Hansen
 
1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, IntroductionCornelia Adlhoch
 
Eaaci advocacy-manifesto-nov2014
Eaaci advocacy-manifesto-nov2014Eaaci advocacy-manifesto-nov2014
Eaaci advocacy-manifesto-nov2014Georgi Daskalov
 
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...jangeissler
 

Similar to Biological agents and prevention of work-related diseases: a review for experts (20)

Biological agents and prevention of work-related diseases: a review for non-e...
Biological agents and prevention of work-related diseases: a review for non-e...Biological agents and prevention of work-related diseases: a review for non-e...
Biological agents and prevention of work-related diseases: a review for non-e...
 
An EU-OSHA perspective on the challenges of preventing work-related accidents...
An EU-OSHA perspective on the challenges of preventing work-related accidents...An EU-OSHA perspective on the challenges of preventing work-related accidents...
An EU-OSHA perspective on the challenges of preventing work-related accidents...
 
A healthy environment in Europe for healthier people
A healthy environment in Europe for healthier peopleA healthy environment in Europe for healthier people
A healthy environment in Europe for healthier people
 
Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)
Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)
Eirian Thomas: Chemical safety and chemical threats (SHARP JA WP9)
 
Alert and sentinel approaches for the identification of work-related diseases...
Alert and sentinel approaches for the identification of work-related diseases...Alert and sentinel approaches for the identification of work-related diseases...
Alert and sentinel approaches for the identification of work-related diseases...
 
The relevance of the farming community regarding zoonoses
The relevance of the farming community regarding zoonosesThe relevance of the farming community regarding zoonoses
The relevance of the farming community regarding zoonoses
 
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
 
Catherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCatherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD Coalition
 
HOPITAL SLIDE.pptx
HOPITAL SLIDE.pptxHOPITAL SLIDE.pptx
HOPITAL SLIDE.pptx
 
100014228.ppt
100014228.ppt100014228.ppt
100014228.ppt
 
European Platform for Chronic and Respiratory Diseases
European Platform for Chronic and Respiratory DiseasesEuropean Platform for Chronic and Respiratory Diseases
European Platform for Chronic and Respiratory Diseases
 
Health, Climate and Innovation
Health, Climate and InnovationHealth, Climate and Innovation
Health, Climate and Innovation
 
A Workers’ Survey on Exposure to Cancer Risk Factors in Europe: An Innovative...
A Workers’ Survey on Exposure to Cancer Risk Factors in Europe: An Innovative...A Workers’ Survey on Exposure to Cancer Risk Factors in Europe: An Innovative...
A Workers’ Survey on Exposure to Cancer Risk Factors in Europe: An Innovative...
 
ICOH 2015 - EU OSH Strategies and national examples
ICOH 2015 - EU OSH Strategies and national examplesICOH 2015 - EU OSH Strategies and national examples
ICOH 2015 - EU OSH Strategies and national examples
 
Timo Minssen - Helex Presentation on Law & Antibiotics
Timo Minssen - Helex Presentation on Law & AntibioticsTimo Minssen - Helex Presentation on Law & Antibiotics
Timo Minssen - Helex Presentation on Law & Antibiotics
 
1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction
 
HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...
HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...
HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...
 
Eaaci advocacy-manifesto-nov2014
Eaaci advocacy-manifesto-nov2014Eaaci advocacy-manifesto-nov2014
Eaaci advocacy-manifesto-nov2014
 
Vol 45 no_19-english
Vol 45 no_19-englishVol 45 no_19-english
Vol 45 no_19-english
 
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...
 

More from European Agency for Safety and Health at Work - EU-OSHA

ΠΡΟΒΛΕΨΗ ΤΩΝ ΝΕΩΝ ΚΑΙ ΑΝΑΔΥΟΜΕΝΩΝ ΚΙΝΔΥΝΩΝ ΕΠΑΓΓΕΛΜΑΤΙΚΗΣ ΑΣΦΑΛΕΙΑΣ ΚΑΙ ΥΓΕΙΑ...
ΠΡΟΒΛΕΨΗ ΤΩΝ ΝΕΩΝ ΚΑΙ ΑΝΑΔΥΟΜΕΝΩΝ ΚΙΝΔΥΝΩΝ ΕΠΑΓΓΕΛΜΑΤΙΚΗΣ ΑΣΦΑΛΕΙΑΣ ΚΑΙ ΥΓΕΙΑ...ΠΡΟΒΛΕΨΗ ΤΩΝ ΝΕΩΝ ΚΑΙ ΑΝΑΔΥΟΜΕΝΩΝ ΚΙΝΔΥΝΩΝ ΕΠΑΓΓΕΛΜΑΤΙΚΗΣ ΑΣΦΑΛΕΙΑΣ ΚΑΙ ΥΓΕΙΑ...
ΠΡΟΒΛΕΨΗ ΤΩΝ ΝΕΩΝ ΚΑΙ ΑΝΑΔΥΟΜΕΝΩΝ ΚΙΝΔΥΝΩΝ ΕΠΑΓΓΕΛΜΑΤΙΚΗΣ ΑΣΦΑΛΕΙΑΣ ΚΑΙ ΥΓΕΙΑ...European Agency for Safety and Health at Work - EU-OSHA
 
ПРОГНОЗИ ЗА НОВИ И НОВОВЪЗНИКВАЩИ РИСКОВЕ ЗА БЗР ВСЛЕДСТВИЕ НА ЦИФРОВИЗАЦИЯТА...
ПРОГНОЗИ ЗА НОВИ И НОВОВЪЗНИКВАЩИ РИСКОВЕ ЗА БЗР ВСЛЕДСТВИЕ НА ЦИФРОВИЗАЦИЯТА...ПРОГНОЗИ ЗА НОВИ И НОВОВЪЗНИКВАЩИ РИСКОВЕ ЗА БЗР ВСЛЕДСТВИЕ НА ЦИФРОВИЗАЦИЯТА...
ПРОГНОЗИ ЗА НОВИ И НОВОВЪЗНИКВАЩИ РИСКОВЕ ЗА БЗР ВСЛЕДСТВИЕ НА ЦИФРОВИЗАЦИЯТА...European Agency for Safety and Health at Work - EU-OSHA
 

More from European Agency for Safety and Health at Work - EU-OSHA (20)

Preventing musculoskeletal disorders (MSDs) through worker participation
Preventing musculoskeletal disorders (MSDs) through worker participationPreventing musculoskeletal disorders (MSDs) through worker participation
Preventing musculoskeletal disorders (MSDs) through worker participation
 
New Developments and Trends in Psychosocial Risk Management by Xabier Irastor...
New Developments and Trends in Psychosocial Risk Management by Xabier Irastor...New Developments and Trends in Psychosocial Risk Management by Xabier Irastor...
New Developments and Trends in Psychosocial Risk Management by Xabier Irastor...
 
How are Workplaces Managing OSH on a Daily Basis? by Xabier Irastorza
How are Workplaces Managing OSH on a Daily Basis? by Xabier IrastorzaHow are Workplaces Managing OSH on a Daily Basis? by Xabier Irastorza
How are Workplaces Managing OSH on a Daily Basis? by Xabier Irastorza
 
OSH World Congress - OSH barometer by Lothar Lieck
OSH World Congress - OSH barometer by Lothar LieckOSH World Congress - OSH barometer by Lothar Lieck
OSH World Congress - OSH barometer by Lothar Lieck
 
OSH World Congress - Value of OSH by Dietmar Elsler
OSH World Congress - Value of OSH by Dietmar Elsler OSH World Congress - Value of OSH by Dietmar Elsler
OSH World Congress - Value of OSH by Dietmar Elsler
 
On the move — MSDs and avoiding prolonged static sitting at work
On the move — MSDs and avoiding prolonged static sitting at workOn the move — MSDs and avoiding prolonged static sitting at work
On the move — MSDs and avoiding prolonged static sitting at work
 
Working with chronic musculoskeletal disorders
Working with chronic musculoskeletal disordersWorking with chronic musculoskeletal disorders
Working with chronic musculoskeletal disorders
 
Work-related Musculoskeletal Disorders (MSDs): statistics
Work-related Musculoskeletal Disorders (MSDs): statisticsWork-related Musculoskeletal Disorders (MSDs): statistics
Work-related Musculoskeletal Disorders (MSDs): statistics
 
Risk Assessment for Musculoskeletal Disorders (MSDs)
Risk Assessment for Musculoskeletal Disorders (MSDs)Risk Assessment for Musculoskeletal Disorders (MSDs)
Risk Assessment for Musculoskeletal Disorders (MSDs)
 
Introduction to Musculoskeletal Disorders (MSDs) prevention
Introduction to Musculoskeletal Disorders (MSDs) preventionIntroduction to Musculoskeletal Disorders (MSDs) prevention
Introduction to Musculoskeletal Disorders (MSDs) prevention
 
EU-OSHA Stakeholder Satisfaction Survey 2020
EU-OSHA Stakeholder Satisfaction Survey 2020EU-OSHA Stakeholder Satisfaction Survey 2020
EU-OSHA Stakeholder Satisfaction Survey 2020
 
ANÁLISE PROSPETIVA DOS RISCOS NOVOS E EMERGENTES RELACIONADOS COM A DIGITALIZ...
ANÁLISE PROSPETIVA DOS RISCOS NOVOS E EMERGENTES RELACIONADOS COM A DIGITALIZ...ANÁLISE PROSPETIVA DOS RISCOS NOVOS E EMERGENTES RELACIONADOS COM A DIGITALIZ...
ANÁLISE PROSPETIVA DOS RISCOS NOVOS E EMERGENTES RELACIONADOS COM A DIGITALIZ...
 
PROGNOZY DO ROKU 2025 DOTYCZĄCE NOWYCH I POJAWIAJĄCYCH SIĘ ZAGROŻEŃ ZWIĄZANY...
PROGNOZY DO ROKU 2025 DOTYCZĄCE NOWYCH I POJAWIAJĄCYCH SIĘ ZAGROŻEŃ ZWIĄZANY...PROGNOZY DO ROKU 2025 DOTYCZĄCE NOWYCH I POJAWIAJĄCYCH SIĘ ZAGROŻEŃ ZWIĄZANY...
PROGNOZY DO ROKU 2025 DOTYCZĄCE NOWYCH I POJAWIAJĄCYCH SIĘ ZAGROŻEŃ ZWIĄZANY...
 
PROSPECTIVE SUR LES RISQUES NOUVEAUX ET ÉMERGENTS EN MATIÈRE DE SST LIÉS À LA...
PROSPECTIVE SUR LES RISQUES NOUVEAUX ET ÉMERGENTS EN MATIÈRE DE SST LIÉS À LA...PROSPECTIVE SUR LES RISQUES NOUVEAUX ET ÉMERGENTS EN MATIÈRE DE SST LIÉS À LA...
PROSPECTIVE SUR LES RISQUES NOUVEAUX ET ÉMERGENTS EN MATIÈRE DE SST LIÉS À LA...
 
AVISO SOBRE LOS RIESGOS NUEVOS Y EMERGENTES DE SST RELACIONADOS CON LA DIGIT...
AVISO SOBRE LOS RIESGOS NUEVOS Y EMERGENTES DE SST RELACIONADOS CON LA DIGIT...AVISO SOBRE LOS RIESGOS NUEVOS Y EMERGENTES DE SST RELACIONADOS CON LA DIGIT...
AVISO SOBRE LOS RIESGOS NUEVOS Y EMERGENTES DE SST RELACIONADOS CON LA DIGIT...
 
ΠΡΟΒΛΕΨΗ ΤΩΝ ΝΕΩΝ ΚΑΙ ΑΝΑΔΥΟΜΕΝΩΝ ΚΙΝΔΥΝΩΝ ΕΠΑΓΓΕΛΜΑΤΙΚΗΣ ΑΣΦΑΛΕΙΑΣ ΚΑΙ ΥΓΕΙΑ...
ΠΡΟΒΛΕΨΗ ΤΩΝ ΝΕΩΝ ΚΑΙ ΑΝΑΔΥΟΜΕΝΩΝ ΚΙΝΔΥΝΩΝ ΕΠΑΓΓΕΛΜΑΤΙΚΗΣ ΑΣΦΑΛΕΙΑΣ ΚΑΙ ΥΓΕΙΑ...ΠΡΟΒΛΕΨΗ ΤΩΝ ΝΕΩΝ ΚΑΙ ΑΝΑΔΥΟΜΕΝΩΝ ΚΙΝΔΥΝΩΝ ΕΠΑΓΓΕΛΜΑΤΙΚΗΣ ΑΣΦΑΛΕΙΑΣ ΚΑΙ ΥΓΕΙΑ...
ΠΡΟΒΛΕΨΗ ΤΩΝ ΝΕΩΝ ΚΑΙ ΑΝΑΔΥΟΜΕΝΩΝ ΚΙΝΔΥΝΩΝ ΕΠΑΓΓΕΛΜΑΤΙΚΗΣ ΑΣΦΑΛΕΙΑΣ ΚΑΙ ΥΓΕΙΑ...
 
ПРОГНОЗИ ЗА НОВИ И НОВОВЪЗНИКВАЩИ РИСКОВЕ ЗА БЗР ВСЛЕДСТВИЕ НА ЦИФРОВИЗАЦИЯТА...
ПРОГНОЗИ ЗА НОВИ И НОВОВЪЗНИКВАЩИ РИСКОВЕ ЗА БЗР ВСЛЕДСТВИЕ НА ЦИФРОВИЗАЦИЯТА...ПРОГНОЗИ ЗА НОВИ И НОВОВЪЗНИКВАЩИ РИСКОВЕ ЗА БЗР ВСЛЕДСТВИЕ НА ЦИФРОВИЗАЦИЯТА...
ПРОГНОЗИ ЗА НОВИ И НОВОВЪЗНИКВАЩИ РИСКОВЕ ЗА БЗР ВСЛЕДСТВИЕ НА ЦИФРОВИЗАЦИЯТА...
 
Estimation of the costs of work-related injuries and diseases in five countries
Estimation of the costs of work-related injuries and diseases in five countriesEstimation of the costs of work-related injuries and diseases in five countries
Estimation of the costs of work-related injuries and diseases in five countries
 
OiRA online and interactive risk assessment
OiRA online and interactive risk assessmentOiRA online and interactive risk assessment
OiRA online and interactive risk assessment
 
Future scenarios and the impact of digitalization on OSH
Future scenarios and the impact of digitalization on OSHFuture scenarios and the impact of digitalization on OSH
Future scenarios and the impact of digitalization on OSH
 

Recently uploaded

Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 

Recently uploaded (20)

Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 

Biological agents and prevention of work-related diseases: a review for experts

  • 1. Safety and health at work is everyone’s concern. It’s good for you. It’s good for business. Biological agents and prevention of work-related diseases: a review © EU-OSHA, Matej Kastelic
  • 2. 2 https://osha.europa.eu Background of the project  EU OSH Strategic Framework 2014-2020 • One of the 3 major challenges: to improve the prevention of work-related diseases  Background • 230,000 workers died worldwide in 2014 due to communicable diseases caused by biological agents – around 7,000 in Europe (GLOBAL ESTIMATES 2017) • About 15% of cancers attributed to carcinogenic infections, (Helicobacter pylori, Human papillomavirus (HPV), Hepatitis B, C, Epstein-Barr, etc.) (WHO) • FR (2010): 4,7 million workers (22%) exposed to biological agents −healthcare/social work (74.9%), agriculture (38.8 %), Horeca (44.7 %), personal services (58.8 %), green jobs (46.4%) (SUMER 2010) • Waste management and healthcare are growing sectors
  • 3. 3 https://osha.europa.eu Part of OSH overview on work-related diseases  2015-2019 − Desk research, expert interviews and focus groups − Description of policies or monitoring systems and data analysis − Workshops with experts and EU-OSHA stakeholders  Outputs: − Seminar online summaries, literature reviews, reports, articles and recommendations, ppts for policy makers and for experts − Translations – portfolio approach: articles, report summaries, − National workshops under FAST 2019  Building on previous EU-OSHA work − Dangerous substances incl. biological agents, etc. ©EU-OSHA, Roberta Pizzigoni
  • 4. 4 https://osha.europa.eu Objectives of the review  Raise awareness on exposure to biological agents in exposed professions, especially those with unintentional use of biological agents;  Increase information on health problems related to exposure to biological agents;  Support efforts to prioritise and structure the prevention of work-related health problems linked to biological agents. ©Shutterstock/DariaCherry  Overview on the current knowledge on relevant exposures and on recognised diseases;  Particular focus on emerging issues and new professions, e.g. green jobs;  Link to biological agents directive – unintentional exposures;  Collect information from recording and compensation systems;  Identify gaps in data/knowledge.
  • 5. 5 https://osha.europa.eu Complementary to previous and ongoing work EU-OSHA campaigns European Week 2003 and HWC 2018-19 Expert Forecast: Main emerging biological risks  Global epidemics (avian flu, HIV, etc.) • Workers at the frontline of contamination  Drug-resistant micro-organisms (MRSA, tuberculosis, etc.)  Poor Indoor Air Quality: Indoor mould • Poor maintenance of air-conditioning, construction & insulation technics  Waste treatment: micro-organisms, mould, endotoxins, etc.  Poor risk assessment: little information on dose-effect relationship; measurement is challenging; low awareness level Selected reviews:  Legionella and Legionnaires’ disease: a policy overview  Biological agents and pandemics: review of the literature and national policies
  • 6. 6 https://osha.europa.eu Beneficiaries & intermediaries  Beneficiaries • Policy makers at national and EU level, including social partners; • Legislators; • Researchers; • Actors in occupational diseases recognition and statistical data collection (e.g. national social security organisations); • Actors at enterprise level (e.g. health and safety manager, health and safety representative, trades union representative) and intermediaries involved in setting up company policies; • Sectoral organisations; • Policy makers in other, related areas, for example at the sectoral level, or regarding employment, public health and environmental policies.  Intermediaries • Intermediaries involved in setting up company policies; • Sectoral organisations • Policy makers at national and EU level, incl. social partners • Researchers ©INSHT
  • 7. 7 https://osha.europa.eu Project overview: structure  Task-specific objectives: • Task 1: provide overview of types of biological factors and health problems relevant to workplaces (emphasis on unintentional exposures) • Task 2: provide information on examples of policies regarding work-related diseases due to biological agents, their success factors and obstacles and their transferability • Task 3: learn from the experience of intermediaries to identify specific upcoming risks and lack of measures regarding work- related diseases due to biological agents • Task 4: Stakeholder workshop to present and discuss findings • Task 5: Final report summarizing results
  • 8. 8 https://osha.europa.eu Results  Workers exposed in many professions, but little information on prevalence or incidence of exposure or diseases  High risk sectors: healthcare, agriculture (arable farming and livestock farming), waste and wastewater treatment, occupations that involve travelling and contact with travellers.  Other professions: wood working, metal work, restauration (of artworks), archives, etc.. © EU-OSHA, Verislav Stanchev  Overall lack of awareness of the risks from biological agents in all sectors, except healthcare and laboratories  Exposure to mixtures: • organic dust in agriculture and other professions, causing infections and allergies • surgical smoke  Allergenic agents, sectors and occupations at clear risk: • agricultural and fisheries sector, food industry, wood-working and metal industry and the waste treatment sector • well known allergenic occupational diseases are asthma in farmers and farmer's lung (hypersensitivity pneumonitis)
  • 9. 9 https://osha.europa.eu Emerging biological risks  Climate change --> newly occurring microorganisms that have spread to other regions (e.g. via ticks and mosquitoes)  Environmental legislation leading to changing patterns in waste management  Waste treatment and composting - specific allergens  Changing travelling patterns and volunteer schemes in third world countries (chikungunya, Crimean-Congo fever) ©EU-OSHA, Audrius Bagdonas  Migration flow to Europe – transfer of biological agents from the Middle East and Africa  Multi-resistant bacteria and epidemics (e.g. of zoonoses), risk to health professions and agriculture  Expected increase in green jobs - increased sensitisation to biomass-related allergens  Potential re-emerging diseases, e.g. Q-fever, tuberculosis and influenza No system in place to respond quickly to emerging risks
  • 10. 10 https://osha.europa.eu Vulnerable groups  For most occupations, no specific information  Critical doses and circumstances of exposure may be different for these groups  Trainees and new professionals, young workers  lack of experience & knowledge  Pregnant women  People with pre-existing diseases, like lung diseases, allergies and asthma, chronic diseases  People treated with immunosuppressants, especially fungal diseases  Cleaning and maintenance workers, working at different workplaces and for different employers  Temporary and undocumented workers  Foreign workers  Healthcare: • Workers in home care (not always well informed) • Health workers who travel for work Courtesy of AUVA
  • 11. 11 https://osha.europa.eu Monitoring of diseases (1)  A selection of monitoring systems analysed and described (DE, DK, FI, FR, NL, UK)  Wide range of types of monitoring systems for diseases  Diseases due to biological agents reported in generic registration systems  no specific focus on biological agents • Exceptions in healthcare and systems for compulsory reporting (e.g. for hepatitis or tuberculosis)  Proportion of diseases due to biological agents relatively low, except allergic diseases  Unequal coverage of zoonoses  Coverage of sectors and occupations unequal • e.g. agriculture, self-employed ‼ Underreporting of diseases (including those related to biological agents) ©EU-OSHA, Dominic Wigley
  • 12. 12 https://osha.europa.eu Monitoring of diseases (2)  Systems used for monitoring diseases / exposures vary widely: • Differences in what is monitored, how frequently and level of detail • Under-reporting • Little information on exposure to biological agents at the workplace  Unclear how data from monitoring systems is linked to prevention at the workplace  Data from national registration systems on occupational diseases and causes can be a valuable source of information • Data often not publicly available • Available in NL and UK • Difficult for companies or branch organisations to access information relevant for their sector  Risk of biological agents often not a high priority on the national political agenda due to lack of clear evidence, occupational exposure limit (OEL) values and evaluation methods © CRISTINA VATIELLI
  • 13. 13 https://osha.europa.eu Monitoring of exposures to biological agents  Information on exposure to biological agents limited Monitoring systems do not exist in all countries • Of evaluated countries, only in Germany, France and Finland occupational exposures monitored and registered on regular basis.  Exposures not measured frequently  Possible to derive occupational exposure limits (OELs) for biological agents that have toxic or allergenic effects as for chemicals (e.g. endotoxins) BUT • Lack of data on exposure and effects (exposure-effect relationships) • Lack of knowledge on exposure and pathogenicity © Fotolyse - Fotolia  Innovative measurement methods for identification and exposure easurement  FINJEM, MEGA database, COLCHIC database  French TOE as a basis for categories of exposure
  • 14. 14 https://osha.europa.eu Challenges for measurement of biological agents  Exposure depends on growth conditions, availability of water and other substrates  Dependent on temperature/season of the year. ! A measurement can only be regarded as a snapshot of the concentration in the air.  Measurement methods record concentrations in air, but not from contaminated surfaces or instruments and through skin  Cultivation and colony counting does not capture substances generated by the organisms, or toxic/allergenic compounds. Some cannot be measured through cultivation ©EU OSHA/Jim Holmes  Alternative methods  (electron)microscope counting  DNA sequencing or staining  Focus on more general markers for exposure (like endotoxins, glucans, peptidoglycans)  Stimulate development of standardised measurement methods and OELs for these markers
  • 15. 15 https://osha.europa.eu Monitoring systems - recommendations  To achieve comparability • Make information available to all stakeholders • Use a standard set of key parameters • Agree on the level of detail. • Consider providing information in English  Output from the systems in each country should be published according to • Causative agents (exposures) • Industries/sectors • Jobs/occupations • Age • Gender  All sectors and occupations and all groups of workers to be covered by disease monitoring, recording and recognition  Good examples: Classification systems in France (TOE) or in Germany (TRBAs, GESTIS) ©EU-OSHA, Sandra Milosevic
  • 16. 16 https://osha.europa.eu Monitoring systems – recommendations (2)  Regular revision and update of the lists of occupational diseases  Emphasis on respiratory diseases and skin diseases and on exposures to service workers  Better use of the information in existing databases  ‘ODIT’ instrument (Spreeuwers et al. 2009) - tool to assess quality of registration systems for occupational disease and ability to provide information for prevention  Defined indicators for high and low quality  Detection of new and/or emerging risks requires a different strategy / instruments than current risks • Training and commitment from (occupational) physicians • FR, BE/NL: examples of detection systems (RNV3P, Signaal) ©PIXELTASTER, Arpad Pinter
  • 17. 17 https://osha.europa.eu Better prevention needed  Respecting the hierarchy of prevention measures • Most measures identified in the review related to PPE and other individual measures • Awareness-raising needed about the existing legal framework • Applying collective rather than personal measures  Lack of access to appropriate PPE or lack of appropriate storage areas for PPE  Plans to deal with accidental exposure  Measures for safe waste collection and handling and transport of biological agents  OSH services needed for workers in exposed sectors  Right to appropriate health surveillance • needs to lead to prevention measures • right for other workers when a health problem is identified • prescreening for allergy vs. prevention measures ©Stoyko Sabotanov ©Dries Vanderschaeghe
  • 18. 18 https://osha.europa.eu Better prevention (2)  Hygiene measures • separation of break and changing rooms • appropriate washing and toilet facilities • separation of work and other clothing  Differentiation between ‘clean’ and ‘dirty’ areas (black-white areas) • especially in waste management and farming • avoiding contamination  Vaccination • right for workers to be informed about advantages/disadvantages • information in annexes to biological agents Directive (label) • reasons for low vaccination rates?  Protection from accidental exposure • needlestick injuries, cuts, bites • diseases transmitted by vectors (e.g. Ticks) ©EU OSHA/Jim Holmes ©Manuel Alejandro Ortega Gálvez ©EU OSHA/Jim Holmes
  • 19. 19 https://osha.europa.eu Importance of allergens  Multifactorial - exact cause of the allergy cannot easily be identified  Causes: organic dust, moulds in buildings, flour dust, industrial enzymes, specific bacteria occurring for example in waste management, wood processing and metalwork  Sectors at risk: waste and wastewater treatment, construction, fisheries, food industry, textile industry, wood-working, metal industry ! Allergies most recognised diseases, e.g. farmers lung  Prevention: • Dust- and aerosol-avoiding measures • Ventilation • Closed systems • Hygiene measures • PPE • Black-white areas ©Audrius Bagdonas ©INSHT
  • 20. 20 https://osha.europa.eu Conclusions  Classification of biological agents according to level of risk requires a risk assessment for every biological agent at a workplace • often not feasible due to the large variation of biological agents at workplaces • for many biological agents no data available  Huge variation in conditions of workplaces means a uniform preventive approach is difficult to realise.  Policies mentioned by experts for all sectors successful • Facilitated by: − good national visibility and approachability of experts, − availability of research results and reports, − lobbying groups, media attention and public awareness. • Obstacles: − a lack of effective methods to collect quantified data, − lack of a clear reporting system for emerging diseases and risky situations from local to national level − lack of collaboration between ministries, expert organisations and other relevant stakeholders. ©EU-OSHA, Raymond Widawski
  • 21. 21 https://osha.europa.eu Good practice examples  OSH services for farming sector – Finland • Consultation and health checks for farmers  Technical rules for biological agents, GESTIS database – Germany • Guidance for different sectors and biological agents  Cooperation of committees for hazardous substances and for biological agents - Germany • Guidance for protection of workers from sensitisers  Prevention in animal laboratories – Netherlands • Mixture of organisational, technical and personal measures to protect workers from allergies • Apply to workers, clients and providers  Sentinel and alert systems • RNV3P – France • THOR – UK • SIGNAAL – Belgium and Netherlands ©Timurs Subhankulovs
  • 22. 22 https://osha.europa.eu Synergies with public health needed!  Compulsory reporting in public health for some diseases and exposures: • Pandemics such as avian influenza • Tuberculosis • Brucellosis, etc…  Monitor spread and outbreaks of diseases  Sentinel approach as in public health notification systems could be followed  Expert networks in public health and occupational hygiene, e.g. regarding antibiotics and multiple resistance  General practitioners can act as mediators for the prevention message and are important carriers of information  Clear intervention plan when a new risk is identified – from first signs to alert for prevention ©EU-OSHA, Zijl Reinier
  • 23. 23 https://osha.europa.eu Recommendations – awareness-raising and communication  Better link between research community, authorities and the OSH experts at workplaces  Information exchange needed between countries • filling the gaps by additional research • existing data, knowledge, experiences and best practices in different sectors • more systematic assessments of specific exposures or specific occupations • communication to benefit policy makers and workers/employers ©David Tijero Osorio  Raising more awareness: • among occupational physicians - observing an increase in incidence of known diseases in novel occupational settings • among general practitioners - possible link between observed health effects and (previous) work environment of a patient • among new / young workers in relevant sectors and occupations, through e.g. vocational education • among employers on their legal obligations
  • 24. 24 https://osha.europa.eu Recommendations – European level  Consider wider definition of biological agents: • In addition to living (micro)organisms, substances or structures from living or dead organisms (such as exotoxins), allergens and mixtures of biological agents (bioaerosols or organic dust) • Broader definition of biological agents already applied in various Member States • Synergy of requirements for chemical agents and biological agents  A wider range of occupations considered to be ‘at risk’ should be taken into account in the Directive or guidance • Take into account unintentional exposure situations • Take into account “risky” jobs (e.g. maintenance workers, cleaners)  Include reference to vulnerable groups  Emerging risks: • European (or even global) (warning) system would make it possible to respond to emerging risks more quickly and in a more structured way • Alert function in existing or new systems ©David Tijero Osorio
  • 25. 25 https://osha.europa.eu Thank you for your attention Visit our webpages https://osha.europa.eu/en/themes/work-related-diseases/biological-agents
  • 26. 26 https://osha.europa.eu Copyright ©European Agency for Safety and Health at Work, 2019 Reproduction is authorised provided the source is acknowledged. For reproduction or use of any photo under any other copyright than EU-OSHA, permission must be sought directly from the copyright holder.